Pathophysiology of chorea and bradykinesia in Huntington's disease
- PMID: 10348461
- DOI: 10.1002/1531-8257(199905)14:3<398::aid-mds1003>3.0.co;2-f
Pathophysiology of chorea and bradykinesia in Huntington's disease
Abstract
This article reviews the neurophysiological abnormalities described in Huntington's disease. Among the typical features of choreic movements are variable and random patterns of electromyographic (EMG) activity, including cocontraction of agonist and antagonist muscles. Studies of premotor potentials show that choreic movements are not preceded by a Bereitschaftspotential, therefore demonstrating that choreic movement is involuntary. Early cortical median-nerve somatosensory-evoked potentials have reduced amplitudes and the reduction correlates with reduced glucose consumption in the caudate nucleus. Long-latency stretch reflexes evoked in the small hand muscles are depressed. These findings may reflect failed thalamocortical relay of sensory information. In Huntington's disease, the R2 response of the blink reflex has prolonged latencies, diminished amplitudes, and greater habituation than normal. These abnormalities correlate with the severity of chorea in the face. Patients with Huntington's disease perform simple voluntary movements more slowly than normal subjects and with an abnormal triphasic EMG pattern. Bradykinesia is also present during their performance of simultaneous and sequential movements. Eye movements show abnormalities similar to those seen in arm movements. In Huntington's disease, arm movement execution is associated with reduced PET activation of cortical frontal areas. Studies using transcranial magnetic stimulation show that patients with Huntington's disease have normal corticospinal conduction but some patients have a prolonged cortical silent period. Bradykinesia results from degeneration of the basal ganglia output to the supplementary motor areas concerned with the initiation and maintenance of sequential movements. The coexisting hyperkinetic and hypokinetic movement disorders in patients with Huntington's disease probably reflect the involvement of direct and indirect pathways in the basal ganglia-thalamus-cortical motor circuit.
Similar articles
-
The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movement.Brain. 1988 Apr;111 ( Pt 2):223-44. doi: 10.1093/brain/111.2.223. Brain. 1988. PMID: 2967729
-
Electromyographic silent period after transcranial brain stimulation in Huntington's disease.Mov Disord. 1994 Mar;9(2):178-82. doi: 10.1002/mds.870090209. Mov Disord. 1994. PMID: 8196679
-
Impaired antagonist inhibition may contribute to akinesia and bradykinesia in Huntington's disease.Clin Neurophysiol. 2003 Feb;114(2):295-305. doi: 10.1016/s1388-2457(02)00371-1. Clin Neurophysiol. 2003. PMID: 12559237
-
Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease.Mov Disord. 2001 May;16(3):407-23. doi: 10.1002/mds.1096. Mov Disord. 2001. PMID: 11391734 Review.
-
Huntington's disease.Psychiatr Clin North Am. 1997 Dec;20(4):791-807. doi: 10.1016/s0193-953x(05)70345-2. Psychiatr Clin North Am. 1997. PMID: 9443350 Review.
Cited by
-
Ferroptosis: From regulation of lipid peroxidation to the treatment of diseases.Cell Biol Toxicol. 2023 Jun;39(3):827-851. doi: 10.1007/s10565-022-09778-2. Epub 2022 Dec 2. Cell Biol Toxicol. 2023. PMID: 36459356 Review.
-
Role of hypokinesia and bradykinesia in gait disturbances in Huntington's disease: a biomechanical study.J Neurol. 2006 Jan;253(1):73-80. doi: 10.1007/s00415-005-0929-2. Epub 2005 Aug 17. J Neurol. 2006. PMID: 16096818
-
Fuzzy Drug Targets: Disordered Proteins in the Drug-Discovery Realm.ACS Omega. 2023 Mar 8;8(11):9729-9747. doi: 10.1021/acsomega.2c07708. eCollection 2023 Mar 21. ACS Omega. 2023. PMID: 36969402 Free PMC article. Review.
-
Characteristics and occurrence of speech impairment in Huntington's disease: possible influence of antipsychotic medication.J Neural Transm (Vienna). 2014 Dec;121(12):1529-39. doi: 10.1007/s00702-014-1229-8. Epub 2014 May 9. J Neural Transm (Vienna). 2014. PMID: 24809686
-
Break-up and recovery of harmony between direct and indirect pathways in the basal ganglia: Huntington's disease and treatment.Cogn Neurodyn. 2024 Oct;18(5):2909-2924. doi: 10.1007/s11571-024-10125-w. Epub 2024 May 30. Cogn Neurodyn. 2024. PMID: 39555304
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical